Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIMDW
Ainos
$0.18
+6.1%
$0.13
$0.03
$0.37
N/AN/A17,935 shs100 shs
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
$15.00
$15.32
$3.00
$95.04
N/AN/A1,915 shsN/A
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
C$3.50
-2.5%
C$3.71
C$2.59
C$5.60
N/AN/A1,593 shs200 shs
Hamilton Thorne Ltd. stock logo
HTLZF
Hamilton Thorne
$1.59
+0.6%
$1.59
$0.90
$1.63
N/AN/A29,614 shs421,800 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIMDW
Ainos
+6.06%+78.57%-16.03%+56.25%+153.99%
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
0.00%+11.11%+11.11%-25.74%-65.10%
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
0.00%-9.90%-4.61%-4.22%-12.16%
Hamilton Thorne Ltd. stock logo
HTLZF
Hamilton Thorne
0.00%0.00%0.00%0.00%+46.24%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AIMDW
Ainos
N/AN/AN/AN/AN/AN/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/AN/AN/AN/AN/AN/AN/AN/A
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
N/AN/AN/AN/AN/AN/AN/AN/A
Hamilton Thorne Ltd. stock logo
HTLZF
Hamilton Thorne
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIMDW
Ainos
0.00
N/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
0.00
N/AN/AN/A
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
0.00
N/AN/AN/A
Hamilton Thorne Ltd. stock logo
HTLZF
Hamilton Thorne
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIMDW
Ainos
$106.21KN/AN/AN/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/AN/AN/AN/AN/AN/A
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
N/AN/AN/AN/AN/AN/A
Hamilton Thorne Ltd. stock logo
HTLZF
Hamilton Thorne
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIMDW
Ainos
N/AN/A0.00N/AN/AN/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/AN/A0.00N/AN/AN/AN/AN/A
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
N/AN/A0.00N/AN/AN/AN/AN/A
Hamilton Thorne Ltd. stock logo
HTLZF
Hamilton Thorne
N/AN/A0.00N/AN/AN/AN/A8/12/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AIMDW
Ainos
N/AN/AN/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/AN/AN/AN/AN/A
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
N/AN/AN/AN/AN/A
Hamilton Thorne Ltd. stock logo
HTLZF
Hamilton Thorne
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
AIMDW
Ainos
N/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/A
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
N/A
Hamilton Thorne Ltd. stock logo
HTLZF
Hamilton Thorne
N/A

Insider Ownership

CompanyInsider Ownership
AIMDW
Ainos
N/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/A
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
N/A
Hamilton Thorne Ltd. stock logo
HTLZF
Hamilton Thorne
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
AIMDW
Ainos
40N/AN/ANot Optionable
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
2N/AN/ANot Optionable
BICO Group AB (publ) stock logo
CLLKF
BICO Group AB (publ)
880N/AN/ANot Optionable
Hamilton Thorne Ltd. stock logo
HTLZF
Hamilton Thorne
N/AN/AN/ANot Optionable

Recent News About These Companies

Hamilton Thorne Goes Private, Delists from TSX

Media Sentiment Over Time

Ainos NASDAQ:AIMDW

$0.18 +0.01 (+6.06%)
As of 06/23/2025 08:07 AM Eastern

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

Bone Biologics stock logo

Bone Biologics NASDAQ:BBLGW

$15.00 0.00 (0.00%)
As of 06/20/2025

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

BICO Group AB (publ) stock logo

BICO Group AB (publ) OTCMKTS:CLLKF

C$3.50 -0.09 (-2.46%)
As of 06/20/2025 10:23 AM Eastern

BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing. The Biosciences segment provides instruments that enable the handling of cells and rare samples, and rapid transfer of liquids and reagents, as well as downstream analysis platforms. The Bioautomation segment offers end-to-end products and services in precision dispensing, advanced sample preparation, multiplex analysis and assay miniaturization, diagnostic and medical device manufacturing for life science and diagnostic industries. It primarily serves medical, pharmaceutical, and cosmetic industries. The company offers its products through sales organizations, as well as through an extensive distributor network. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was incorporated in 2016 and is headquartered in Gothenburg, Sweden.

Hamilton Thorne stock logo

Hamilton Thorne OTCMKTS:HTLZF

$1.59 +0.01 (+0.63%)
As of 12/2/2024

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. The company offers precision laser systems and imaging systems for biology markets. It also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services. In addition, the company manufactures and distributes medical products for reproductive medicine; manufactures bespoke workstations, incubators, and equipment for IVF laboratories; researches, designs, develops, sells, installs, and services in-vitro diagnostic systems; and manufactures ovum pickup needles, catheters, and other devices. Further, the company offers Cell-Tek Microscope Chamber, a product for controlling temperature, air flow, humidification, and air quality; laminar flow workstations, incubators, and related products; and artificial intelligence enabled CASA software, consumables, and image analysis systems for the ART and laboratory markets, as well as capital equipment and consumables, software, and other services. It sells its products and services under Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, MICROPTIC, Gynétics, and Embryotech brand names through a direct sales force in the United States, Germany, France, Australia, Denmark, Belgium, Spain, and the United Kingdom, as well as through distributors to fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 100 countries. Hamilton Thorne Ltd. is headquartered in Beverly, Massachusetts.